SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-025103
Filing Date
2022-11-14
Accepted
2022-11-14 17:29:09
Documents
78
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bior-20220930.htm   iXBRL 10-Q 3851272
2 EX-31.1 bior-ex31_1.htm EX-31.1 22858
3 EX-31.2 bior-ex31_2.htm EX-31.2 23264
4 EX-32.1 bior-ex32_1.htm EX-32.1 20280
  Complete submission text file 0000950170-22-025103.txt   12525940

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bior-20220930_lab.xml EX-101.LAB 609120
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bior-20220930_pre.xml EX-101.PRE 466899
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bior-20220930_cal.xml EX-101.CAL 62174
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bior-20220930.xsd EX-101.SCH 68240
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bior-20220930_def.xml EX-101.DEF 319631
72 EXTRACTED XBRL INSTANCE DOCUMENT bior-20220930_htm.xml XML 2205209
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39334 | Film No.: 221388058
SIC: 2834 Pharmaceutical Preparations